Clash!
Medical Marketing & Media (MM&M), one of the more interesting industry magazines, just printed a piece by my friend and colleague, Harry Sweeney, called "Clash of Civilizations"(see figure below).The juxtaposition of...
DTC without the Risk
The Coalition for Healthcare Communication (CHC) -- comprised of major advertising, marketing and PR organizations, including the American Association of Advertising Agencies, the Association of National Advertisers, and the Public...
Drug Development: Science vs. Marketing
According to an article in the March 27, 2006 edition of the Wall Street Journal ("Bureaucracy Buster? Glaxo Lets Scientists Choose Its New Drugs"), large pharmaceutical companies like GSK are experimenting...
Free Dinner for Brand Managers!
If you are a pharmaceutical brand manager, I would like to offer you a FREE dinner at a fine restaurant in New Brunswick, NJ on Monday, April 3, 2006. As you...
Generic Detailing
Last Monday, the Wall Street Journal ran a story entitled: "As Drug Bill Soars, Some Doctors Get An 'Unsales' Pitch" and prefaced it with the tagline "Negative Advertising." Here's the first...
Buzz ‘n Blogs — Stealth Marketing
I recently attended and survived another pharmaceutical eMarketing conference (CBI's eMarketing for the Pharmaceutical Industry). As usual, I came away feeling like a time traveler returning from a visit to the...
Immutable Laws of DTC Domain Naming
My friend RJ Lewis wrote a column entitled "The importance of a Name" that recently appeared in Product Management Today. His premise is: "Choosing and capitalizing on a memorable domain name...
Paid Inclusion: Too Hot for Pharma Marketing?
Next week I will be participating in a search engine marketing panel discussion at CBI's 5th Annual eMarketing for the Pharmaceutical Industry conference in Philadelphia. Everything I know about search engine...
Off-label Marketing: Next State Issue
California leads the way in many things, including laws to reign in pharmaceutical marketing and sales. Where California leads, many other states follow. The latest proposed California law is Assembly Bill...
GSK’s “Plain Talk” Flawed
This discussion starts with the post I made a few days ago about GlaxoSmithKline (GSK) using sales reps to spread the word about the value of brand drugs (see "Sales Reps...
